Defining and Treating Borderline Resectable Pancreatic Cancer.

Opinion Statement: Patients with borderline resectable pancreatic ductal adenocarcinoma (BR PDAC) should receive preoperative chemotherapy with or without radiation therapy, with the intent to eradicate occult metastatic cancer cells, to select patients with a "locally dominant cancer phenotype" for...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Treatment Options in Oncology Vol. 21; no. 9
Autores principales:	Perri, Giampaolo, Prakash, Laura, Katz, Matthew H. G.
Formato:	research Journal Article
Publicado:	Springer Nature Sep2020
Acceso en línea:	Ver este registro en EBSCOhost